# Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer

> **NCT03127111** · — · NOT_YET_RECRUITING · sponsor: **Renmin Hospital of Wuhan University** · enrollment: 300 (estimated)

## Conditions studied

- Stage III Colorectal Cancer

## Interventions

- **GENETIC:** Gene mutations analysis
- **GENETIC:** Gene methylation analysis
- **GENETIC:** Gene expression analysis
- **GENETIC:** SNP analysis
- **GENETIC:** Protein expression analysis

## Key facts

- **NCT ID:** NCT03127111
- **Lead sponsor:** Renmin Hospital of Wuhan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03127111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03127111, "Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03127111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*